Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Operating Expenses (2023 - 2026)

Adagio Medical Holdings has reported Operating Expenses over the past 4 years, most recently at $5.2 million for Q1 2026.

  • Quarterly Operating Expenses fell 29.7% to $5.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Mar 2026, up 3.92% year-over-year, with the annual reading at $21.9 million for FY2025, 65.11% down from the prior year.
  • Operating Expenses was $5.2 million for Q1 2026 at Adagio Medical Holdings, up from $4.0 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $9.1 million in Q3 2023 and troughed at $4.0 million in Q4 2025.
  • The 4-year median for Operating Expenses is $5.6 million (2023), against an average of $6.2 million.
  • Year-over-year, Operating Expenses tumbled 50.04% in 2024 and then increased 25.54% in 2025.
  • A 4-year view of Operating Expenses shows it stood at $5.4 million in 2023, then fell by 15.78% to $4.6 million in 2024, then dropped by 12.93% to $4.0 million in 2025, then skyrocketed by 31.05% to $5.2 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Operating Expenses are $5.2 million (Q1 2026), $4.0 million (Q4 2025), and $5.7 million (Q3 2025).